Global Anti-HIV Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Anti-HIV Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Anti-HIV Drugs industry chain, the market status of Hospitals and Clinics (Multi-class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors), Retail Pharmacies (Multi-class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Anti-HIV Drugs.

Regionally, the report analyzes the Anti-HIV Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Anti-HIV Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Anti-HIV Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Anti-HIV Drugs industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Multi-class Combination Drugs, Nucleoside Reverse Transcriptase Inhibitors).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Anti-HIV Drugs market.

Regional Analysis: The report involves examining the Anti-HIV Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Anti-HIV Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Anti-HIV Drugs:
Company Analysis: Report covers individual Anti-HIV Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Anti-HIV Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Retail Pharmacies).

Technology Analysis: Report covers specific technologies relevant to Anti-HIV Drugs. It assesses the current state, advancements, and potential future developments in Anti-HIV Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Anti-HIV Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Anti-HIV Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Multi-class Combination Drugs
    Nucleoside Reverse Transcriptase Inhibitors
    Non-nucleoside Reverse Transcriptase Inhibitors
    HIV Integrase Strand Transfer Inhibitors

Market segment by Application
    Hospitals and Clinics
    Retail Pharmacies
    Online Pharmacies

Market segment by players, this report covers
    Gilead Sciences
    ViiV Healthcare
    Merck & Co.
    AbbVie
    Roche Holding AG
    Teva Pharmaceuticals
    Bristol Myers Squibb
    Pfizer
    Shionogi
    Cipla
    Boehringer Ingelheim

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Anti-HIV Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-HIV Drugs, with revenue, gross margin and global market share of Anti-HIV Drugs from 2019 to 2024.
Chapter 3, the Anti-HIV Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Anti-HIV Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-HIV Drugs.
Chapter 13, to describe Anti-HIV Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Anti-HIV Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Anti-HIV Drugs by Type
        1.3.1 Overview: Global Anti-HIV Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Anti-HIV Drugs Consumption Value Market Share by Type in 2023
        1.3.3 Multi-class Combination Drugs
        1.3.4 Nucleoside Reverse Transcriptase Inhibitors
        1.3.5 Non-nucleoside Reverse Transcriptase Inhibitors
        1.3.6 HIV Integrase Strand Transfer Inhibitors
    1.4 Global Anti-HIV Drugs Market by Application
        1.4.1 Overview: Global Anti-HIV Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals and Clinics
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Anti-HIV Drugs Market Size & Forecast
    1.6 Global Anti-HIV Drugs Market Size and Forecast by Region
        1.6.1 Global Anti-HIV Drugs Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Anti-HIV Drugs Market Size by Region, (2019-2030)
        1.6.3 North America Anti-HIV Drugs Market Size and Prospect (2019-2030)
        1.6.4 Europe Anti-HIV Drugs Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Anti-HIV Drugs Market Size and Prospect (2019-2030)
        1.6.6 South America Anti-HIV Drugs Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Anti-HIV Drugs Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Gilead Sciences
        2.1.1 Gilead Sciences Details
        2.1.2 Gilead Sciences Major Business
        2.1.3 Gilead Sciences Anti-HIV Drugs Product and Solutions
        2.1.4 Gilead Sciences Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Gilead Sciences Recent Developments and Future Plans
    2.2 ViiV Healthcare
        2.2.1 ViiV Healthcare Details
        2.2.2 ViiV Healthcare Major Business
        2.2.3 ViiV Healthcare Anti-HIV Drugs Product and Solutions
        2.2.4 ViiV Healthcare Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 ViiV Healthcare Recent Developments and Future Plans
    2.3 Merck & Co.
        2.3.1 Merck & Co. Details
        2.3.2 Merck & Co. Major Business
        2.3.3 Merck & Co. Anti-HIV Drugs Product and Solutions
        2.3.4 Merck & Co. Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Merck & Co. Recent Developments and Future Plans
    2.4 AbbVie
        2.4.1 AbbVie Details
        2.4.2 AbbVie Major Business
        2.4.3 AbbVie Anti-HIV Drugs Product and Solutions
        2.4.4 AbbVie Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 AbbVie Recent Developments and Future Plans
    2.5 Roche Holding AG
        2.5.1 Roche Holding AG Details
        2.5.2 Roche Holding AG Major Business
        2.5.3 Roche Holding AG Anti-HIV Drugs Product and Solutions
        2.5.4 Roche Holding AG Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Roche Holding AG Recent Developments and Future Plans
    2.6 Teva Pharmaceuticals
        2.6.1 Teva Pharmaceuticals Details
        2.6.2 Teva Pharmaceuticals Major Business
        2.6.3 Teva Pharmaceuticals Anti-HIV Drugs Product and Solutions
        2.6.4 Teva Pharmaceuticals Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Teva Pharmaceuticals Recent Developments and Future Plans
    2.7 Bristol Myers Squibb
        2.7.1 Bristol Myers Squibb Details
        2.7.2 Bristol Myers Squibb Major Business
        2.7.3 Bristol Myers Squibb Anti-HIV Drugs Product and Solutions
        2.7.4 Bristol Myers Squibb Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Bristol Myers Squibb Recent Developments and Future Plans
    2.8 Pfizer
        2.8.1 Pfizer Details
        2.8.2 Pfizer Major Business
        2.8.3 Pfizer Anti-HIV Drugs Product and Solutions
        2.8.4 Pfizer Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Pfizer Recent Developments and Future Plans
    2.9 Shionogi
        2.9.1 Shionogi Details
        2.9.2 Shionogi Major Business
        2.9.3 Shionogi Anti-HIV Drugs Product and Solutions
        2.9.4 Shionogi Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Shionogi Recent Developments and Future Plans
    2.10 Cipla
        2.10.1 Cipla Details
        2.10.2 Cipla Major Business
        2.10.3 Cipla Anti-HIV Drugs Product and Solutions
        2.10.4 Cipla Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Cipla Recent Developments and Future Plans
    2.11 Boehringer Ingelheim
        2.11.1 Boehringer Ingelheim Details
        2.11.2 Boehringer Ingelheim Major Business
        2.11.3 Boehringer Ingelheim Anti-HIV Drugs Product and Solutions
        2.11.4 Boehringer Ingelheim Anti-HIV Drugs Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Boehringer Ingelheim Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Anti-HIV Drugs Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Anti-HIV Drugs by Company Revenue
        3.2.2 Top 3 Anti-HIV Drugs Players Market Share in 2023
        3.2.3 Top 6 Anti-HIV Drugs Players Market Share in 2023
    3.3 Anti-HIV Drugs Market: Overall Company Footprint Analysis
        3.3.1 Anti-HIV Drugs Market: Region Footprint
        3.3.2 Anti-HIV Drugs Market: Company Product Type Footprint
        3.3.3 Anti-HIV Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Anti-HIV Drugs Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Anti-HIV Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Anti-HIV Drugs Consumption Value Market Share by Application (2019-2024)
    5.2 Global Anti-HIV Drugs Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Anti-HIV Drugs Consumption Value by Type (2019-2030)
    6.2 North America Anti-HIV Drugs Consumption Value by Application (2019-2030)
    6.3 North America Anti-HIV Drugs Market Size by Country
        6.3.1 North America Anti-HIV Drugs Consumption Value by Country (2019-2030)
        6.3.2 United States Anti-HIV Drugs Market Size and Forecast (2019-2030)
        6.3.3 Canada Anti-HIV Drugs Market Size and Forecast (2019-2030)
        6.3.4 Mexico Anti-HIV Drugs Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Anti-HIV Drugs Consumption Value by Type (2019-2030)
    7.2 Europe Anti-HIV Drugs Consumption Value by Application (2019-2030)
    7.3 Europe Anti-HIV Drugs Market Size by Country
        7.3.1 Europe Anti-HIV Drugs Consumption Value by Country (2019-2030)
        7.3.2 Germany Anti-HIV Drugs Market Size and Forecast (2019-2030)
        7.3.3 France Anti-HIV Drugs Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Anti-HIV Drugs Market Size and Forecast (2019-2030)
        7.3.5 Russia Anti-HIV Drugs Market Size and Forecast (2019-2030)
        7.3.6 Italy Anti-HIV Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Anti-HIV Drugs Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Anti-HIV Drugs Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Anti-HIV Drugs Market Size by Region
        8.3.1 Asia-Pacific Anti-HIV Drugs Consumption Value by Region (2019-2030)
        8.3.2 China Anti-HIV Drugs Market Size and Forecast (2019-2030)
        8.3.3 Japan Anti-HIV Drugs Market Size and Forecast (2019-2030)
        8.3.4 South Korea Anti-HIV Drugs Market Size and Forecast (2019-2030)
        8.3.5 India Anti-HIV Drugs Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Anti-HIV Drugs Market Size and Forecast (2019-2030)
        8.3.7 Australia Anti-HIV Drugs Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Anti-HIV Drugs Consumption Value by Type (2019-2030)
    9.2 South America Anti-HIV Drugs Consumption Value by Application (2019-2030)
    9.3 South America Anti-HIV Drugs Market Size by Country
        9.3.1 South America Anti-HIV Drugs Consumption Value by Country (2019-2030)
        9.3.2 Brazil Anti-HIV Drugs Market Size and Forecast (2019-2030)
        9.3.3 Argentina Anti-HIV Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Anti-HIV Drugs Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Anti-HIV Drugs Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Anti-HIV Drugs Market Size by Country
        10.3.1 Middle East & Africa Anti-HIV Drugs Consumption Value by Country (2019-2030)
        10.3.2 Turkey Anti-HIV Drugs Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Anti-HIV Drugs Market Size and Forecast (2019-2030)
        10.3.4 UAE Anti-HIV Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Anti-HIV Drugs Market Drivers
    11.2 Anti-HIV Drugs Market Restraints
    11.3 Anti-HIV Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Anti-HIV Drugs Industry Chain
    12.2 Anti-HIV Drugs Upstream Analysis
    12.3 Anti-HIV Drugs Midstream Analysis
    12.4 Anti-HIV Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Anti-HIV Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Anti-HIV Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Anti-HIV Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Anti-HIV Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 6. Gilead Sciences Major Business
    Table 7. Gilead Sciences Anti-HIV Drugs Product and Solutions
    Table 8. Gilead Sciences Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Gilead Sciences Recent Developments and Future Plans
    Table 10. ViiV Healthcare Company Information, Head Office, and Major Competitors
    Table 11. ViiV Healthcare Major Business
    Table 12. ViiV Healthcare Anti-HIV Drugs Product and Solutions
    Table 13. ViiV Healthcare Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. ViiV Healthcare Recent Developments and Future Plans
    Table 15. Merck & Co. Company Information, Head Office, and Major Competitors
    Table 16. Merck & Co. Major Business
    Table 17. Merck & Co. Anti-HIV Drugs Product and Solutions
    Table 18. Merck & Co. Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Merck & Co. Recent Developments and Future Plans
    Table 20. AbbVie Company Information, Head Office, and Major Competitors
    Table 21. AbbVie Major Business
    Table 22. AbbVie Anti-HIV Drugs Product and Solutions
    Table 23. AbbVie Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. AbbVie Recent Developments and Future Plans
    Table 25. Roche Holding AG Company Information, Head Office, and Major Competitors
    Table 26. Roche Holding AG Major Business
    Table 27. Roche Holding AG Anti-HIV Drugs Product and Solutions
    Table 28. Roche Holding AG Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Roche Holding AG Recent Developments and Future Plans
    Table 30. Teva Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 31. Teva Pharmaceuticals Major Business
    Table 32. Teva Pharmaceuticals Anti-HIV Drugs Product and Solutions
    Table 33. Teva Pharmaceuticals Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. Teva Pharmaceuticals Recent Developments and Future Plans
    Table 35. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
    Table 36. Bristol Myers Squibb Major Business
    Table 37. Bristol Myers Squibb Anti-HIV Drugs Product and Solutions
    Table 38. Bristol Myers Squibb Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Bristol Myers Squibb Recent Developments and Future Plans
    Table 40. Pfizer Company Information, Head Office, and Major Competitors
    Table 41. Pfizer Major Business
    Table 42. Pfizer Anti-HIV Drugs Product and Solutions
    Table 43. Pfizer Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Pfizer Recent Developments and Future Plans
    Table 45. Shionogi Company Information, Head Office, and Major Competitors
    Table 46. Shionogi Major Business
    Table 47. Shionogi Anti-HIV Drugs Product and Solutions
    Table 48. Shionogi Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Shionogi Recent Developments and Future Plans
    Table 50. Cipla Company Information, Head Office, and Major Competitors
    Table 51. Cipla Major Business
    Table 52. Cipla Anti-HIV Drugs Product and Solutions
    Table 53. Cipla Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Cipla Recent Developments and Future Plans
    Table 55. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 56. Boehringer Ingelheim Major Business
    Table 57. Boehringer Ingelheim Anti-HIV Drugs Product and Solutions
    Table 58. Boehringer Ingelheim Anti-HIV Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Boehringer Ingelheim Recent Developments and Future Plans
    Table 60. Global Anti-HIV Drugs Revenue (USD Million) by Players (2019-2024)
    Table 61. Global Anti-HIV Drugs Revenue Share by Players (2019-2024)
    Table 62. Breakdown of Anti-HIV Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in Anti-HIV Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 64. Head Office of Key Anti-HIV Drugs Players
    Table 65. Anti-HIV Drugs Market: Company Product Type Footprint
    Table 66. Anti-HIV Drugs Market: Company Product Application Footprint
    Table 67. Anti-HIV Drugs New Market Entrants and Barriers to Market Entry
    Table 68. Anti-HIV Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global Anti-HIV Drugs Consumption Value (USD Million) by Type (2019-2024)
    Table 70. Global Anti-HIV Drugs Consumption Value Share by Type (2019-2024)
    Table 71. Global Anti-HIV Drugs Consumption Value Forecast by Type (2025-2030)
    Table 72. Global Anti-HIV Drugs Consumption Value by Application (2019-2024)
    Table 73. Global Anti-HIV Drugs Consumption Value Forecast by Application (2025-2030)
    Table 74. North America Anti-HIV Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 75. North America Anti-HIV Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 76. North America Anti-HIV Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. North America Anti-HIV Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. North America Anti-HIV Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 79. North America Anti-HIV Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 80. Europe Anti-HIV Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Europe Anti-HIV Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Europe Anti-HIV Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 83. Europe Anti-HIV Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 84. Europe Anti-HIV Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Anti-HIV Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Anti-HIV Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 87. Asia-Pacific Anti-HIV Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 88. Asia-Pacific Anti-HIV Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 89. Asia-Pacific Anti-HIV Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 90. Asia-Pacific Anti-HIV Drugs Consumption Value by Region (2019-2024) & (USD Million)
    Table 91. Asia-Pacific Anti-HIV Drugs Consumption Value by Region (2025-2030) & (USD Million)
    Table 92. South America Anti-HIV Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 93. South America Anti-HIV Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 94. South America Anti-HIV Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 95. South America Anti-HIV Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 96. South America Anti-HIV Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. South America Anti-HIV Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Middle East & Africa Anti-HIV Drugs Consumption Value by Type (2019-2024) & (USD Million)
    Table 99. Middle East & Africa Anti-HIV Drugs Consumption Value by Type (2025-2030) & (USD Million)
    Table 100. Middle East & Africa Anti-HIV Drugs Consumption Value by Application (2019-2024) & (USD Million)
    Table 101. Middle East & Africa Anti-HIV Drugs Consumption Value by Application (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Anti-HIV Drugs Consumption Value by Country (2019-2024) & (USD Million)
    Table 103. Middle East & Africa Anti-HIV Drugs Consumption Value by Country (2025-2030) & (USD Million)
    Table 104. Anti-HIV Drugs Raw Material
    Table 105. Key Suppliers of Anti-HIV Drugs Raw Materials
List of Figures
    Figure 1. Anti-HIV Drugs Picture
    Figure 2. Global Anti-HIV Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Anti-HIV Drugs Consumption Value Market Share by Type in 2023
    Figure 4. Multi-class Combination Drugs
    Figure 5. Nucleoside Reverse Transcriptase Inhibitors
    Figure 6. Non-nucleoside Reverse Transcriptase Inhibitors
    Figure 7. HIV Integrase Strand Transfer Inhibitors
    Figure 8. Global Anti-HIV Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 9. Anti-HIV Drugs Consumption Value Market Share by Application in 2023
    Figure 10. Hospitals and Clinics Picture
    Figure 11. Retail Pharmacies Picture
    Figure 12. Online Pharmacies Picture
    Figure 13. Global Anti-HIV Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Anti-HIV Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Market Anti-HIV Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 16. Global Anti-HIV Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 17. Global Anti-HIV Drugs Consumption Value Market Share by Region in 2023
    Figure 18. North America Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 20. Asia-Pacific Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 21. South America Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 22. Middle East and Africa Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 23. Global Anti-HIV Drugs Revenue Share by Players in 2023
    Figure 24. Anti-HIV Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 25. Global Top 3 Players Anti-HIV Drugs Market Share in 2023
    Figure 26. Global Top 6 Players Anti-HIV Drugs Market Share in 2023
    Figure 27. Global Anti-HIV Drugs Consumption Value Share by Type (2019-2024)
    Figure 28. Global Anti-HIV Drugs Market Share Forecast by Type (2025-2030)
    Figure 29. Global Anti-HIV Drugs Consumption Value Share by Application (2019-2024)
    Figure 30. Global Anti-HIV Drugs Market Share Forecast by Application (2025-2030)
    Figure 31. North America Anti-HIV Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 32. North America Anti-HIV Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 33. North America Anti-HIV Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 34. United States Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 35. Canada Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 36. Mexico Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 37. Europe Anti-HIV Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 38. Europe Anti-HIV Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 39. Europe Anti-HIV Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 40. Germany Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 41. France Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 42. United Kingdom Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 43. Russia Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 44. Italy Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 45. Asia-Pacific Anti-HIV Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 46. Asia-Pacific Anti-HIV Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 47. Asia-Pacific Anti-HIV Drugs Consumption Value Market Share by Region (2019-2030)
    Figure 48. China Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 49. Japan Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 50. South Korea Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 51. India Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 52. Southeast Asia Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 53. Australia Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 54. South America Anti-HIV Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 55. South America Anti-HIV Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 56. South America Anti-HIV Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 57. Brazil Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 58. Argentina Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 59. Middle East and Africa Anti-HIV Drugs Consumption Value Market Share by Type (2019-2030)
    Figure 60. Middle East and Africa Anti-HIV Drugs Consumption Value Market Share by Application (2019-2030)
    Figure 61. Middle East and Africa Anti-HIV Drugs Consumption Value Market Share by Country (2019-2030)
    Figure 62. Turkey Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 63. Saudi Arabia Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 64. UAE Anti-HIV Drugs Consumption Value (2019-2030) & (USD Million)
    Figure 65. Anti-HIV Drugs Market Drivers
    Figure 66. Anti-HIV Drugs Market Restraints
    Figure 67. Anti-HIV Drugs Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Anti-HIV Drugs in 2023
    Figure 70. Manufacturing Process Analysis of Anti-HIV Drugs
    Figure 71. Anti-HIV Drugs Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Companies Mentioned

Gilead Sciences
ViiV Healthcare
Merck & Co.
AbbVie
Roche Holding AG
Teva Pharmaceuticals
Bristol Myers Squibb
Pfizer
Shionogi
Cipla
Boehringer Ingelheim